Quantum Health Appoints Dr. Stanley Crittenden as New Chief Medical Officer

Value-Based Care Expert to Expand Company’s Clinical Operations, Programs and Pharmacy Management Strategy

Quantum Health, the leading consumer healthcare navigation and care coordination company, announced today it has named Dr. Stanley Crittenden, MD, FASN, as its corporate Chief Medical Officer. In his role, Dr. Crittenden will be responsible for Quantum Health’s clinical strategy, including Utilization Management, Pharmacy and Clinical programs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240812304065/en/

Quantum Health appoints Dr. Stanley Crittenden as new Chief Medical Officer. (Photo: Business Wire)

“We are very excited to announce the hiring of Dr. Crittenden, who has an unwavering focus on clinical excellence and is deeply passionate about doing his part in improving the healthcare system for all. He will help enhance our existing clinical operations and strategy along with growing our value-based care programs and clinical focus here at Quantum Health,” said Zane Burke, Chief Executive Officer of Quantum Health.

Quantum Health currently offers a range of clinical support for members via the company’s in-house clinical teams of medical directors, Personal Care Guide nurses and other clinical specialists who interact directly with physicians and healthcare providers to deliver a full continuum of care. Quantum Health’s core services support members confronting a broad range of healthcare journeys with proprietary technology, industry-leading healthcare navigation and care coordination, which includes expert benefits answers and guidance, access to optimal doctors and care resources, direct communications between providers and specialists, counseling, integrated behavioral health monitoring, access to educational and community resources, assistance with billing issues and medical appeals, and efficient service authorizations for treating physicians. Quantum Health’s clinical advisory strategy and leadership includes advisory boards dedicated to oncology, musculoskeletal (MSK) and behavioral health, and each provides expanded benefits support services and high-quality care options to employer members through clinical, emotional and financial resources that address specific oncology, MSK and behavioral health diagnoses.

Dr. Crittenden comes to Quantum Health from Evergreen Nephrology, a Rubicon Founders portfolio company, where he served as Chief Medical Officer. During his time there, he led the creation of their payer and provider-integrated value-based care delivery model and its supporting technology stack. As an expert in value-based care models, he also had responsibility for clinical product development and led the service teams responsible for utilization management, case management, health equity programs and business development. Prior to Evergreen, Dr. Crittenden served in physician executive roles with both Anthem and Humana, where he was able to translate his direct patient care experience to create programs that delivered improved health outcomes in both commercial and Medicare Advantage service lines. Dr. Crittenden attended both undergraduate and medical school at Tulane University. He completed residency in internal medicine at The University of Chicago and fellowship in nephrology at Weill Cornell Medical College and is board-certified in internal medicine and nephrology.

“Quantum Health invented and now leads the navigation market, and I am thrilled with the opportunity to build upon what Quantum Health has created and ensure our Healthcare Warriors® are best positioned to tackle the many challenges our fragmented healthcare system continues to generate for our members and clients,” said Dr. Crittenden. “I am excited to join a team rapidly evolving its clinical programs, operations and scale to enable the company to drive even more engagement and better health outcomes along with better supporting high-cost and complex care members and continuing our focus on pharmacy management for clients.”

“As the industry’s leading independent navigation platform that supports over 3 million members and over 500 self-insured employer clients, Quantum Health’s unique clinical model and teams play a critical role in the healthcare experience we provide and outcomes we’re known for delivering at scale across our diverse member base. Dr. Crittenden will be instrumental in expediting our efforts to bring new clinical models to market that drive better health experience for members and value for our clients,” said Steven Knight, Chief Operating Officer for Quantum Health.

About Quantum Health

Quantum Health celebrates its 25th year as the industry-leading consumer healthcare navigation and care coordination company that delivers an unparalleled consumer experience to its members, as well as validated claims savings and high satisfaction rates for its self-insured employer clients. Quantum Health’s proprietary Real-Time Intercept^® capability identifies opportunities for early intervention in a member’s healthcare journey, resulting in better engagement, outcomes and cost efficiencies.

Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc. 5000, a Great Place to Work by FORTUNE Magazine and Entrepreneur Magazine, and one of FORTUNE’S Best Workplaces in Healthcare. The Women Presidents’ Organization has also ranked Quantum Health as one of the 50 Fastest-Growing Women-Owned/Led Companies for over 15 years.

To learn more about the company, visit Quantum-Health.com, and connect with us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240812304065/en/

"Dr. Crittenden will help enhance our existing clinical operations and strategy along with growing our value-based care programs and clinical focus here at Quantum Health," said Zane Burke, CEO of Quantum Health.